EHA 2025: Real-World Insights on Belantamab Mafodotin in RRMM
/ Fredrik Schjesvold
EHA 2025: Impact of Treating MRD Relapse Post 1L in Multiple Myeloma
/ Frida Bugge Askeland
Advancing Myeloma Research and Treatment: An Interview with Fredrik Schjesvold
/ Fredrik Schjesvold / Jan Andreasen